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Stem cell-based therapy of retinal degenerative conditions is a promising modality to treat blindness, but
requires new strategies to improve the number of functionally integrating cells. Grafting semidifferentiated
retinal tissue rather than progenitors allows preservation of tissue structure and connectivity in retinal grafts,
mandatory for vision restoration. Using human embryonic stem cells (hESCs), we derived retinal tissue growing
in adherent conditions consisting of conjoined neural retina and retinal pigment epithelial (RPE) cells and
evaluated cell fate determination and maturation in this tissue. We found that deriving such tissue in adherent
conditions robustly induces all eye field genes (RX, PAX6, LHX2, SIX3, SIX6) and produces four layers of pure
populations of retinal cells: RPE (expressing NHERF1, EZRIN, RPE65, DCT, TYR, TYRP, MITF, PMEL), early
photoreceptors (PRs) (coexpressing CRX and RCVRN), inner nuclear layer neurons (expressing CALB2), and
retinal ganglion cells [RGCs, expressing BRN3B and Neurofilament (NF) 200]. Furthermore, we found that
retinal progenitors divide at the apical side of the hESC-derived retinal tissue (next to the RPE layer) and then
migrate toward the basal side, similar to that found during embryonic retinogenesis. We detected synapto-
genesis in hESC-derived retinal tissue, and found neurons containing many synaptophysin-positive boutons
within the RGC and PR layers. We also observed long NF200-positive axons projected by RGCs toward the
apical side. Whole-cell recordings demonstrated that putative amacrine and/or ganglion cells exhibited elec-
trophysiological responses reminiscent of those in normal retinal neurons. These responses included voltage-
gated Na+ and K+ currents, depolarization-induced spiking, and responses to neurotransmitter receptor agonists.
Differentiation in adherent conditions allows generation of long and flexible pieces of 3D retinal tissue suitable
for isolating transplantable slices of tissue for retinal replacement therapies.
Introduction
Stem cell-based therapy is a promising approach torepair vision loss, but to this day, it has yet to deliver any
Food and Drug Administration-approved cell replacement
therapies, leaving neuroprotection as the best current alter-
native [1]. Photoreceptors (PRs) and the retinal pigment ep-
ithelium (RPE) are commonly considered the most important
targets of stem cell therapies [1–3]. PRs and RPE interact
functionally and structurally [2–6], appear to polarize each
other [7], and are reported to show improved engraftment
when transplanted together [8,9]. After engraftment, stem
cell-derived PRs must survive and form functional synaptic
connections. Furthermore, complicating cell-based therapies
is the complex milieu of degenerative pathologies of retinal
tissue. Transplanted dissociated cells may not survive long
term in such abnormal conditions [10]. The survival of
transplanted PRs is especially challenging if the recipient
retina lacks a functional RPE [11]. These considerations lead
to the conclusion that grafting retinal tissue (such as em-
bryonic retina) rather than dissociated PRs may be more ef-
fective for repairing the retina [12] in patients suffering from
advanced retinal degeneration. While fetal tissue challenges
efforts at quality control, lot-to-lot uniformity, ethics, and
scalability [13], human pluripotent stem cells (hPSCs) are a
perpetually renewable source of cells and therefore may be
instrumental in developing industrially scalable therapies
for early and advanced retinal dystrophies such as Leber
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congenital amaurosis (LCA) and retinitis pigmentosa (RP),
and likely age-related macular degeneration (AMD), diabetic
retinopathy (DR), and retinopathy of prematurity (ROP). The
optic nerve remains intact in these blinding conditions, which
enables restoration of connectivity between the 3D retinal
graft and downstream visual nuclei to transmit the PR visual
signals to the cortex [14,15].
Blindness is a major burden on society [16–18] with an
estimated annual cost of $35.4 billion [19]. There are many
unmet clinical needs associated with the challenging task of
treating RP, LCA, AMD, ROP, and DR. About 15 million
Americans currently suffer from AMD [20,21], the leading
cause of vision loss in adults aged over 50 years in devel-
oped nations, with the number of cases projected to nearly
double by 2030. RP is the third most frequent cause of
inherited visual impairment and is estimated to affect up to
100,000 people in the United States and *1.5 million
people worldwide [22]. DR affects 4.2 million adults in the
United States, among them 655,000 have advanced DR with
conditions such as clinically significant macular edema and
proliferative DR that could lead to blindness [23]. These
numbers illustrate the urgent need for new and efficient
retinal therapies.
A viable new direction of treating blindness is retinal
grafting with tissue derived from human embryonic stem
cells (hESCs). Recent reports demonstrated that hESCs and
induced pluripotent stem cells (iPSCs) can generate optic
vesicle- and optic cup-like structures and produce retinal
progenitors that differentiate into RPE, PRs, inner nuclear
layer (INL) neurons, and retinal ganglion cells (RGCs) [24–
26]. Culturing hPSC-derived retinal spheres in suspension
for up to 6 months demonstrated the ability of retinal or-
ganoids to form cell layers, including PRs with outer disk-
like protrusions and photosensitivity [26], which are
challenging to purify in 2D monolayer culture [27]. How-
ever, the main advantage of deriving 3D tissue rather than
PR progenitors is that the organization of embryonic-like
tissue can be preserved. This facilitates subsequent sub-
retinal grafting and likely the survival of PRs. Retinal repair
with human fetal grafts and vision improvements have been
achieved in animals [14,28] and in patients with advanced
retinal degeneration [9,29–31]. Self-organization of 3D
retinal tissue is especially efficient if the transplant includes
the RPE [8,9,30,32]. It has been observed that stem cell-
derived 3D retinas support lamination and outer segment
(OS) outgrowth demonstrates the tissue’s potential to per-
form visual function after grafting. However, the retinal
tissue cannot be too differentiated to survive the surgical
procedure [33]. In addition, the structural rigidity of re-
tinospheres (cultured in suspension) makes it difficult to
isolate a transplantable slice of hESC-derived retina [34].
In this study, we derived immature, long, and flexible
3D retinal tissue from hESCs in adherent conditions. This
tissue containing layers of RPE cells, PRs, INL cells, and
RGCs is capable of forming synapses and exhibiting a
range of electrophysiological responses. The ability of hESC-
derived retinal tissue to form synapses is especially im-
portant as this increases the likelihood of establishing
functional connections with the recipient retinal neurons in
subretinal grafts [14,15]. The results will lay the ground-
work for transitioning this stem cell technology to clinical
trials.
Materials and Methods
Pluripotent hESC culture
The hESC line, WA01 (formerly H1) [35], was obtained
from WiCell at passage (P-23) (mTeSRT1/MatrigelT Plat-
form) and cultured in feeder-free conditions using mTeSR1
protocol and basic fibroblast growth factor (Sigma-Aldrich)
[36,37] with the addition of heparin (10 ng/mL) [38] and
amphotericin-B/gentamicin (Life Technologies) on 1xES-
qualified, growth factor-reduced (GFR) Matrigel-coated
(Fisher Scientific) plates. Cells were passaged every 6–7
days (reaching*80% confluency by day 7) on GFR-coated
35-mm plates using the enzymatic protocol with Versene/
EDTA (at a ratio 1:10) from Lonza Group. RHO-kinase
inhibitor (ROCK) [39] 10mM Y-27632 (Catalog #72302)
was used for initial plating of hESCs from cryostorage, and
then removed from culture media. Colonies containing
clearly visible differentiated cells were marked and me-
chanically removed before passaging with Versene, as re-
commended by mTeSR1 protocol [36].
Retinal differentiation
See Supplementary Data and Supplementary Fig. S1
(Supplementary Data are available online at www.liebertpub
.com/scd) for detailed protocol.
RNA isolation and quantitative reverse
transcription–coupled polymerase chain
reaction analysis of gene expression
Total RNA was prepared from (1) undifferentiated hESCs
(control) and (2) differentiated cells using the RNeasy Mini
kit (Qiagen) according to the manufacturer’s protocol and
our earlier published procedures [27,40]. One microgram
(mg) of RNA was converted to cDNA with the Maxima H
Minus First-strand cDNA synthesis kit (Thermo scientific).
Quantitative polymerase chain reaction (qPCR) analysis was
performed using SsoAdvanced Universal SYBR Green su-
permix (Bio-Rad) on the CFX384 Touch Real-Time PCR
System. Primers were selected using the Universal Probe
Library program (Roche Life science, see primer list in
Supplementary Table S1). All experiments were performed
in triplicates, and the data are expressed as mean –SD. The
comparative Ct method was applied in quantitative real-time
PCR assay according to the ddCt method with GAPDH
as internal control [41]. The data are represented as fold
change over control.
Immunohistochemistry
hESC-derived retinal tissue aggregates growing in ad-
herent condition were fixed in fresh ice-cold paraformal-
dehyde (4% PFA; Sigma-Aldrich) for 15 minutes (min),
rinsed with 1· phosphate-buffered saline (PBS), and washed
thrice in ice-cold PBS (5min each). The aggregates were
cryoprotected in 20% sucrose (prepared in PBS, pH 7.8),
and then 30% sucrose (until tissue sank), and snap-frozen
(dry ice/ethanol bath) in optimum cutting temperature (OCT)
embedding material (Tissue-Tek). hESC-derived retinal tis-
sue aggregates were serially sectioned at 12 mm. The sec-
tions were first permeabilized with 0.1% Triton X-100/PBS
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(PBS-T) at room temperature for 30min, followed by 1 h
of incubation in blocking solution [5% preimmune normal
goat serum ( Jackson Immunoresearch) and 0.1% PBS-T] at
room temperature, and then were incubated with primary
antibodies (Supplementary Table S2) diluted in blocking
solution at 4C overnight. The following day sections were
washed thrice (10–15min each time) with PBS-T, and then
incubated with the corresponding secondary antibodies
(Alexa Fluor 568 goat anti-mouse, Alexa Fluor 488 goat
anti-rabbit, 1:1,000, or vice versa) at room temperature for
45min. The slides were washed thrice with 0.1% PBS-T
solution, incubated with 4¢, 6-diamidino-2-phenylindole
(DAPI) solution (1 mg/mL) for 10min, and then washed
again with 0.1% PBS-T solution. As a negative control for
primary antibody-specific binding, we stained tissue sec-
tions with secondary antibodies only. The specimens were
mounted with ProLong Gold Antifade medium (Life
Technologies) and examined using a Nikon Eclipse Ni
epifluorescent microscope with ZYLA 5.5 sCMOS (AN-
DOR Technologies) black and white charge-coupled de-
vice high-speed camera or Olympus FluoView FV1000
confocal microscope (Olympus). All antibodies are listed
in Supplementary Table S2.
Immunoblot
Total lysates of undifferentiated and differentiated
hESCs were homogenized by motorized handheld homog-
enizer (VWR) in radioimmunoprecipitation assay (RIPA)
buffer containing protease inhibitors (Roche complete). At
least 40 individual large hESC-derived retinal tissue ag-
gregates were collected for immunoblotting. The protein
concentration was measured by using Bradford assay.
Equal concentrations (40 mg) of protein samples were
resolved in 4%–20% gradient sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and then transferred to
the Immobilon-FL membrane (Bio-Rad). Membranes were
blocked with blocking buffer (BLOTTO) for 30min at
room temperature. After blocking, membranes were
incubated with primary antibodies. See Supplementary
Data for details.
Electrophysiological recording
hESC-derived retinal tissue aggregates grown in 35-mm
cell culture dishes were positioned on a fixed-stage upright
microscope (Eclipse FN1; Nikon Instruments) and superfused
by Ames’ medium gassed with 95% O2 5% CO2. The su-
perfusate was delivered to the dish at 2–3mL/min and
maintained at 32C using a temperature controller (Warner
Instruments). Retinal tissue aggregates were visualized using
infrared transillumination and NIS Elements D imaging
software (Nikon Instruments). Whole-cell recordings were
obtained from medium to large round somas located on the
interior of the hESC-derived retinal tissue using either a
MultiClamp 700A or 700B amplifier (Molecular Devices).
Glass micropipettes with tip resistances 6–8MO were pulled
from thick-walled borosilicate tubings on a Narishige PC-10
puller and filled with either a K+- or Cs+-based intracellular
solution (described in Supplementary data). PCLAMP 9 or
PCLAMP 10 software (Molecular Devices) was used for data
acquisition. See the ‘‘Electrophysiological recording - chemicals
and solutions’’ section in Supplementary Data for further
methodological details.
Results
Evaluating retinal development by quantitative
reverse transcription–coupled polymerase chain
reaction identifies markers of all retinal lineages
in 3D retina-like tissue
WA01 hESC cultures maintained pluripotency while
growing in feeder-free conditions (Supplementary Fig. S2).
hESC-derived retinal tissue aggregates started to appear by
about week 4 after initiation of a differentiation protocol and
rapidly increased in size by 6 weeks (Supplementary Fig.
S1). We did not observe further growth between weeks 7
and 12, and maintaining cells on the plates at later time
points (around weeks 10–12) was challenging due to the
visible degradation of Matrigel. The growth of retinal tissue
aggregates in cultures was not synchronous, producing
various shapes and sizes, and the number of such aggregates
varied between 2 and 15 or more per 35-mm plate. Large
and elongated aggregates (Supplementary Fig. S1) were
chosen for further study, which we reasoned may be most
suitable for isolating long and flexible pieces of hESC-
derived retinal tissue for grafting. We analyzed differenti-
ating cells by quantitative reverse transcription–coupled
polymerase chain reaction (qRT-PCR) at 2, 3, 4, and 12
weeks (2D monolayer culture), and also in hESC-derived
retinal tissue at 6 weeks.
Early neuroectoderm (NE), anterior neuroectoderm (ANE),
early neuronal (EN), and the eye field (EYF) markers were
robustly upregulated between 2 and 6 weeks in our neural
cultures, indicating efficient induction of NE and early retinal
cell fate (Fig. 1 and Supplementary Table S3), while astro-
glial (ASTR), oligodendroglial (OLIG), neural crest (NCR),
mesodermal, and endodermal markers were undetectable. We
verified the acquisition of NE fate in differentiating hESC-
derived retinal tissue by tracing the expression of the earliest
pan-neuroectodermal transcription factor, SOX1 [42,43],
[11.2– 0.3]. ANE specification in hESC-derived retinal tissue
was confirmed by tracing the expression of OTX2 [peaked at
4 weeks (7.5– 0.2)] and FOXG1 genes (rising steadily,
218.2– 10.7 at 6 weeks). The acquisition of retinal fate
in hESC-derived retinal tissue was determined by analyzing
the expression of several key eye field genes, [RAX
(206.9– 31.3), LHX2 (88.4– 4.8), SIX3 (9.9– 1.4), SIX6
(13.1– 1.1), and PAX6 (43.7– 1.1)]. Expression of RAX,
PAX6, and LHX2 on a protein level was confirmed by im-
munoblots (Supplementary Fig. S3). Most of the cells in the
developing hESC-derived retinal tissue were strongly positive
for RAX (retina and anterior neural fold homeobox tran-
scription factor), a key retinal cell fate marker [44–47]
(Supplementary Fig. S4). Proneural/retinal markers NEU-
ROD1, responsible for the development of PRs and amacrines
[48], and ASCL1 (MASH1) [49], which determine
competence-restricted progenitor lineage in the retina [50],
demonstrated very high expression reaching a peak at 4
weeks (377.3– 5.5 and 134.2– 12.5, respectively). The
CHX10 marker of multipotential retinal progenitors and bi-
polar cell fate [51,52] was not expressed between 2 and 4
weeks in retinal cultures, but was sharply upregulated in
2780 SINGH ET AL.
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hESC-derived retinal tissue at 6 weeks [98.7– 10.1]. The
IKZF1 [IKAROS], which provides temporal competence to
early, but not late, retinal progenitors [53], was expressed be-
tween 2 and 4weeks after the initiation of retinal differentiation
(3.9– 1.3 and 2.3– 0.0, respectively). Several PR markers
showed high expression in hESC-derived retinal tissue at 6
weeks, specifically CRX [11.2– 0.1], RCVRN [49.2– 1.7],
PDE6B [6.9– 0.1], and OPN1SW [48.4– 4.3]. Key rod cell
fate-determining transcription factors, NRL, NR2E3, and
THRB (TRb2, M-cones) [54], were upregulated 2.0–2.3-fold in
hESC-derived retinal tissue (Fig. 1 and Supplementary Table
S3). Among the genes important for RGC development,
MATH5 [55],BRN3B [56,57], and ISL1weremost upregulated
in hESC-derived retinal tissue (48.1– 4.2, 119.3– 5.8, and
17.2– 2.3, respectively). Mu¨ller glia markers, GLUL and
CCND3, peaked at 4weeks, but were not upregulated in hESC-
derived retinal tissue at 6 weeks. INL markers (PROX1,
CALB1–horizontal cells, CALB2–amacrine cells) were upre-
gulated (9.2– 0.7, 4.3– 0.1 and 2.0– 0.0, respectively). Rod
bipolar marker, PRKCA (PKCa), was not upregulated in
hESC-derived retinal tissue. Last, we observed marked upre-
gulation of key RPE markers [MITF (359.3– 22.9), RPE65
(3035.2– 267.4), TYR (13676.8– 402), TYRP (4446.5– 8.4),
DCT (11462.7– 280.9), and PMEL (6.9 – 0.2)] in hESC-
derived retinal tissue at 6 weeks. (Supplementary Table S3).
Maintaining most 3D retina-like tissue aggregates for 12
weeks on the same plate proved to be challenging due to
Matrigel degradation and dislodging of aggregates from the
plates. However, we evaluated gene expression of hESC-
derived retinal cells growing in 2D culture (12-week time
point, Fig. 1 and Supplementary Table S3).We confirmed that
the expression levels of some key NE, ANE, and EYF
markers continue to increase (compared with that found in 6-
week-old hESC-derived retinal tissue), specifically SOX1
[43.1 – 4.8], FOXG1 [355 – 31.2], SIX3 [13.5– 2.4], LHX2
[214.6 – 9.5], CHX10 [314.0– 12.3], DCX [33.4 – 1.9],
ASCL1 [144.2– 6.4], PROX1 [41.4 – 2.3], CALB1 [35.9 –
2.8], CALB2 [4.8 – 0.3], andNRL [4.9– 0.0]. PRKCA became
detectable only in 12-week-old cultures [2.3 – 0.1]. Im-
portantly, markers of early retinal cell types [58], such as RPE
genes, amacrines (LGR5), EYF (RX, PAX6), RGC (BRN3B,
ISL1, MATH5), and PR (RCVRN), showed reduced expres-
sion compared with hESC-derived retinal tissue at 6 weeks.
Trophic factors. We noted the steady upregulation of
selected retina-specific neurotrophic factor genes from 2 to
4 weeks such as ciliary neurotrophic factor (CNTF, 7.3 – 0.3
at 4 weeks), pigment epithelial-derived factor (PEDF [4]
or SERPINF1 8.5 – 0.6 at 4 weeks), and nerve growth fac-
tor (NGF) (4.7– 0.3 at 4 weeks). Brain-derived neurotrophic
factor (BDNF) and Glial-derived neurotrophic factor (GDNF)
maintained a low expression level. The hESC-derived retinal
tissue showed high expression of PEDF and NGF at 6 weeks
(Supplementary Table S3).
MicroRNA-processing genes (DROSHA, AGO2, PASHA,
DICER). These genes showed similar expression levels
compared with hESCs, while LIN28 was downregulated
(Supplementary Table S3).
Evidence of subdivision of 3D retina-like tissue
into outer and inner neuroblast-like zones
To evaluate the mitotic profiles and the distribution of
dividing progenitors in histological sections of hESC-
derived retinal tissue, we used anti-Ki67 antibody [59]. Ki67
is a widely used marker of cell proliferation present at all
stages of the cell cycle in the dividing cells [60], except for
G0 (dormant or resting phase), with peak levels in mitosis
[61]. We found about 4.5% – 0.8% (n= 4) Ki67-positive
(Ki67 [+]) cells with strong Ki67 nuclear signal (mitosis) in
hESC-derived retinal tissue (Supplementary Fig. S5). The
majority of Ki67 [+] cells localized to the apical side (next
to the RPE layer). Such distribution is typical for cells in the
M-phase undergoing interkinetic nuclear migration in ver-
tebrate retinogenesis [62–67]. It is also characteristic of M-
stage dividing progenitors in other types of developing
stratified neuroepithelia [68]. Ki67 [+] nuclei were enlarged
and had round morphology (mitotic rounding [68]), con-
firming that these cells were not migratory.
Localization of mitotic cells to the apical side in the
large 6-week-old hESC-derived retinal tissue prompted
us to search for the presence of cells with the progenitor
signature. We used antibodies for the catalytic component of
FIG. 1. Quantitative reverse transcription-coupled polymerase chain reaction analysis of human embryonic stem cell
(hESC)-derived retinal cells differentiated in 2D adherent monolayer condition (2, 3, 4, 12 weeks) and in 3D retina-like tissue
(6 weeks). Expression values of key eye field, photoreceptor (PR), horizontal, amacrine, and ganglion cell markers are
presented as fold change over control (pluripotent hESCs, day 0) using the comparative ddCt method [41]. Fold ratio of 1
denotes no change in gene expression.GAPDHwas used as internal control. The analysis was done in technical triplicates. The
error bars represent standard deviation (SD) –mean.
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telomerase (TERT) and stem cell marker, LGR5, and ob-
served a strong signal in the apical side (Supplementary Fig.
S6). Adult stem cell marker, LGR5, originally selected as a
marker of glycinergic amacrine neurons [69], demonstrated
very high gene expression level at 2–3 weeks (306.8 – 6.0
and 280.3 – 2.8, respectively) and remained very high at
6 weeks in hESC-derived retinal tissue (493.7 – 21.8)
(Supplementary Table S3).
RPE in hESC-derived retinal tissue and 2D
retinal monolayer cultures
To better define the similarity between the developing
mammalian retina and the hESC-derived retinal tissue, we
evaluated the presence of RPE cells with antibodies to
human EZRIN [70,71] and EBP50/NHERF [72]. EZRIN,
an actin-binding protein, and EBP50/NHERF1, the ERM-
binding phosphoprotein 50/sodium–hydrogen exchanger
regulatory factor 1, are typical markers of the apical RPE.
Immunohistological analysis found a strong signal in the
apical side of hESC-derived retinal tissue (Fig. 2 and Sup-
plementary Fig. S7). We confirmed the presence of RPE in
hESC-derived retinal tissue by the immunoblot with the
antibody to the RPE-specific marker, MITF (Supplementary
Fig. S3). We did not detect the typical microvilli staining
pattern expected with antibodies to NHERF1 [72] and
EZRIN [2,72]. Nevertheless, we did observe visible pig-
mentation of RPE cells in hESC-derived retinal tissue
(apical side) matching the EZRIN/NHERF1 immunostain-
ing (Supplementary Fig. S7). We were unable to do flat-
mount analysis of this hESC-derived retinal tissue to ob-
serve the typical hexagonal shape of RPE cells because of
the small size of each piece of tissue. However, we observed
the typical honeycomb shape and pigmentation in 2D ad-
herent monolayer cultures (Supplementary Fig. S7d, d¢).
Interestingly, we also observed some RPE cells migrating
along the hESC-derived retinal tissue and sometimes re-
siding on the basal side (Supplementary Fig. S7c). This
possibly explains finding traces of EZRIN/NHERF1 [+] signal
on the other side of hESC-derived retinal tissue section.
Finding layers of early retinal cell types,
synaptogenesis, and axonogenesis
in hESC-derived retinal tissue
Finding an RPE layer prompted us to search for cells with
progenitor markers in the apical side of hESC-derived ret-
inal tissue. OTX2, a paired-type homeodomain protein, is
important for specification and postmitotic function of PRs
[73], bipolar neurons, and RPE [74–77]. OTX2 [+] cells first
appear in the developing PRs, and then in the bipolar and
RPE cells during mammalian retinogenesis [78]. Six or
more enhancers of the OTX2 gene [79] control the timing
and activation of OTX2 at different stages of ANE and oc-
ular development [73,80], including PRs [68] and RPE [81].
We detected a strong presence of OTX2 by the immunoblot
(Supplementary Fig. S3) and immunohistochemistry (IHC)
(Fig. 3a, b, d) in hESC-derived retinal tissue. The pattern of
staining resembled that reported in 6–10-week-old human
fetal retinal sections [81] (Supplementary Table S4). The
majority of OTX2 [+] cells were localized to the apical side
of the hESC-derived retinal tissue. Otx2 is expressed at the
time of the last mitotic cycle in retinal progenitors [54] and
also in early PR precursors committed to the PR cell fate
during mammalian retinogenesis [73]. The nuclei of PRs are
expected to localize near the apical side of developing
mammalian retina [54]. OTX2 [+] cells were also found in
the basal side of hESC-derived retinal tissue and could be-
long to precursors of bipolar cells, which appear in the late
stage of retinogenesis [58]. All OTX2 [+] cells had round
nuclei, indicating that cells are not migrating. To determine
if OTX2 [+] cells in the apical side are mitotic or post-
mitotic, we did confocal IHC analysis with OTX2 and Ki67
antibodies (Fig. 3b–e¢) and found that all OTX2 [+] cells in
the apical side are postmitotic. However, we did not find
colocalization between MAP2, an early postmitotic cyto-
plasmic marker present in developing postmitotic RGCs,
and OTX2 [+] nuclei (Fig. 3a). We found most of the cells in
the ciliary margin-like zone strongly positive for OTX2
FIG. 2. Presence of retinal pigment epithelium (RPE) layer
in hESC-derived retinal tissue. Immunostaining of hESC-
derived retinal tissue (6 weeks) with two mature RPEmarkers,
EZRIN, an actin-binding protein, and ERM-binding phos-
phoprotein50/sodium–hydrogen exchanger regulatory factor1
(EBP50/NHERF1), shows strong staining in the apical side.
Inset represents the magnification of the area marked with
an asterisk. 4¢, 6-diamidino-2-phenylindole (DAPI)-stained
nucleus. Scale bar: 20mm.
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(Fig. 3a, arrows). Similar findings have been reported by
Sasai laboratory [82] and others [83].
Next, we determined the distribution of CRX [+] and
PAX6 [+] cells within the hESC-derived retinal tissue
stained with anti-CRX and anti-PAX6 antibodies. The ma-
jority of cells were positive for PAX6 protein, which is a
reliable eye field marker and is also expressed in multipo-
tential retinal progenitors [84] and later in RGCs and ama-
crine neurons. We found a large number of strongly positive
PAX6 [+] cells near the apical side of hESC-derived retinal
tissue. The apical side of embryonic mammalian retina
contains progenitors [62,63], where they acquire cell fate
after the last mitotic cycle and migrate into the retinal layers
to undergo maturation. The majority of CRX [+] cells were
also localized to the apical side of hESC-derived retinal
tissue. We did not colocalize them with mitotic Ki67 [+]
cells, but the localization of CRX [+] cells at the apical side
of hESC-derived retinal tissue and the round shape of these
CRX [+] nuclei (Fig. 4, insets) provide indirect evidence
that many CRX [+] cells have exited the mitotic cycle and
acquired PR cell fate [85]. CRX is expressed in early
postmitotic PR precursors and is regulated by OTX2
[54,73,74,85]. Both markers robustly localized to the apical
side of hESC-derived retinal tissue in multiple IHC exper-
iments (Figs. 3 and 4). We identified a small number of
CRX [+] cells, which also had residual weak staining for
PAX6, likely indicating ongoing loss of PAX6 expression in
these cells and acquisition of CRX [+] signal. Similar
findings were reported during PR development in mamma-
lian retinogenesis, where PAX6 suppresses premature acti-
vation of CRX [86]. We also found a number of CRX [+]
PAX6 [-] cells in hESC-derived retinal tissue. Many of
these nuclei were elongated (Fig. 4, insets), suggesting the
continuing movement of these cells typical for interkinetic
nuclear migration [63,68] after cell fate acquisition. We
confirmed strong expression of PAX6 and CRX by immu-
noblots (Supplementary Fig. S3).
Identification of CRX [+] cells near the apical side of
hESC-derived retinal tissue (Fig. 4) prompted us to look for
rod–cone PR markers, recoverin (RCVRN) and rhodopsin
(RHO). RCVRN, a calcium-binding protein, plays a key role
in sensory adaptation during phototransduction [87], and
RHO is a major rod PR rim OS protein, which belongs to G-
protein-coupled receptors and is a primary light-sensing
pigment in rods [88]. We found a large number of RCVRN
[+] cells in the layer of cells carrying CRX [+] nuclei (Fig.
5a–a†, c). RCVRN [+] cells and CRX [+] cells were colo-
calized by confocal IHC (Fig. 5b–b†¢). Every RCVRN [+]
cell had a CRX [+] nucleus, although only about half of cells
with CRX [+] nuclei had RCVRN [+] cytoplasm. We also
noted a variety of developmental stages in the RCVRN [+]
PR population, from more to less mature, likely reflecting
the asynchronous nature of PR development in hESC-
derived retinal tissue (Fig. 5c, inset and Supplementary Fig.
S8). However, preferential localization of RCVRN [+] cells
to the apical side was very consistent in retinal sections.
RCVRN [+] cells are found in human embryonic retina at
about fetal weeks 10–13 [24,69,89,90] (Supplementary
Table S4) and in mouse developing retina by embryonic day
18 [85]. No RHO [+] cells were found in several sets of
histological sections, although we saw upregulation of the
RHO gene expression. In developing mouse retina, RHO
could be identified by IHC at postnatal days 2–6 [91], while
few cells could be found immediately at birth (P0).
We assayed the presence of cone PRs in hESC-derived
retinal tissue by IHC using peanut agglutinin (PNA). PNA
FIG. 3. OTX2 [+] cells in hESC-derived retinal tissue are postmitotic. (a) Immunolabeling of hESC-derived retinal tissue
(6 weeks) with antibodies to OTX2 and postmitotic neuronal marker, MAP2. Insets are magnifications of framed area
showing no colocalization between OTX2 and MAP2. Arrows point to the presence of OTX2 [+] cells in the ciliary margin-
like zone. Scale bar: 50 and 10mm. (b–e) Confocal images (single optical sections) showing no colocalization of OTX2 and
Ki67 (marker of cell division) in hESC-derived retinal tissue, indicating that OTX2 [+] cells are postmitotic. DAPI-stained
nucleus. Scale bar: 100 mm. (d¢, e¢) Confocal (z-stack) images of the area marked with an asterisk in (b–e). The confocal
image was virtually resectioned at the x and y planes to confirm the identity of the double-labeled cell. Scale bar: 50mm.
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lectin binds to terminal galactose-beta (1–3) N-acetyl ga-
lactosamine disaccharide residues of glycoconjugates found
on the surface of cone (but not rod) outer/inner segment cell
membranes and cone synaptic pedicles [54]. We noted a
robust punctate PNA staining in the apical side in hESC-
derived retinal tissue (Fig. 5d, inset). Under high magnifi-
cation, PNA staining decorated very short stubby protru-
sions reminiscent of developing PR OSs [2] (Fig. 5d, left
and right insets).
The presence of amacrine neurons in hESC-derived reti-
nal tissue was determined using anti-Calretinin (CALB2)
antibody. Calretinin is a member of the calcium-binding
protein expressed from about embryonic week 11 in human
development (Supplementary Table S4). A large number of
Calretinin [+] amacrine neurons with well-developed axons
were found in all sections (Fig. 5e, arrowheads and insets).
Amacrine neurons localized to the basal side of hESC-
derived retinal tissue, where they migrate after cell fate
acquisition during retinogenesis. We observed a number of
migrating Calretinin [+] cells moving from the apical toward
the basal side (Fig. 5e, purple arrow). Colabeling with CRX
(Fig. 5e) and CALB2 antibodies showed that the PRs and
the amacrines are localized to two different layers.
Next, we examined the presence of RGCs by IHC with
the anti-BRN3B antibody. Transcription factor, BRN3B, is a
member of the POU domain family of transcription factors
critical for RGC differentiation [56,57] and activated by
RGC master cell fate control transcription factor, ATOH7
(MATH5) [55]. In agreement with finding the messages for
BRN3B and MATH5 sharply upregulated by qRT-PCR, we
found the abundant presence of BRN3B [+] nuclei by IHC
in the basal side of hESC-derived retinal tissue (Fig. 6 and
insets). In developing mammalian retina, BRN3B [+] cells
were found starting from embryonic days 13–15 [92]. We
found occasional BRN3B [+] cells migrating from the apical
to the basal side of hESC-derived retinal tissue (Fig. 6, in-
sets). Interestingly, as with RCVRN [+] cells (Supplemen-
tary Fig. S8, double asterisk), we discovered patches of
BRN3B [+] cells located in the peripheral part of the hESC-
derived retinal tissue (Fig. 6, double asterisk). We confirmed
the presence of RGC marker, BRN3A, in hESC-derived
retinal tissue by the immunoblot (Supplementary Fig. S3).
Identification of BRN3B [+] cells in hESC-derived retinal
tissue prompted us to search for RGC axonogenesis and
neuronal maturation. We used anti-NF200 antibody (NF-
Heavy chain, NF-H) specific for mature RGC axons [93].
FIG. 4. Distribution of rod–cone
marker, CRX, and multipotential
retinal progenitor marker, PAX6,
in hESC-derived retinal tissue. Im-
munostaining of hESC-derived reti-
nal tissue (6 weeks) with antibodies
to CRX and PAX6 (a–c). (a) Pre-
ferential localization of CRX [+]
nuclei to the apical side of hESC-
derived retinal tissue (arrows). In-
sets represent the magnification of
the area marked with an asterisk (b).
The white arrows in the first inset
(*) point to a CRX [+] nucleus with
a round shape (indicating post-
mitotic PR progenitor), which is
negative for PAX6. The second in-
set (**) shows several cells, which
are CRX [+], but not PAX6 [+], and
vice versa. Note CRX [+] cells in
the inner neuroblast-like layer are
exclusively of elongated shape, in-
dicating the interkinetic nuclear
migration process in less mature
CRX [+] PR progenitors. Scale bar:
20 and 10mm, respectively.
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FIG. 5. Localization of PR and amacrine markers to the apical and basal sides of hESC-derived retinal tissue. (a–a¢¢)
Low-magnification confocal image of hESC-derived retinal tissue section stained with RCVRN and CRX antibodies. Note
the identical distribution pattern of CRX [+] and RCVRN [+] cells within the apical side. DAPI-stained nucleus. Scale bar:
100 mm. (b–b¢¢¢) High-magnification confocal (z-stack) images (60·, optical zoom 2) of the area marked with an asterisk in
a–a¢¢. The confocal image was virtually resectioned at the x and y planes to confirm the identity of the double-labeled cell.
Note that all cells with RCVRN [+] cytoplasm carry CRX [+] nucleus. However, about half of cells with CRX [+] nuclei
have RCVRN [+] cytoplasm. DAPI-stained nucleus. Scale bar: 100 mm. (c) Epifluorescent image of RCVRN [+] PRs with
more mature morphology (including long cytoplasmic processes) distributed along the apical side. Left (RCVRN) and right
(RCVRN and DAPI) insets represent magnification of the area indicated with an asterisk. DAPI-stained nucleus. (d)
Immunostaining of hESC-derived retinal tissue with cone outer segment marker lectin peanut agglutinin (PNA). PNA
staining pattern was specific to the apical side of hESC-derived retinal tissue (see epifluorescent image in d and the high-
magnification confocal image, left inset). The right inset depicts short PNA [+] protrusions in the apical side (high-
magnification confocal image with 60·, zoom 3). DAPI-stained nucleus. Scale bar: 10 mm. (e) Immunostaining of hESC-
derived retinal tissue with CRX (rod–cone marker) and CALB2 (Calretinin, amacrine marker) antibodies shows localization
of PRs (double arrowheads) and amacrines (arrowheads) to the apical and basal sides, respectively. Inset represents the
magnification of the area (*) showing the well-developed CALB2 [+] axons of amacrine neurons. The inset with a purple
arrow is the magnification of the area shown with a double asterisk (**) and depicts an elongated CALB2 [+] cell migrating
from the apical toward the basal side of hESC-derived retinal tissue. DAPI-stained nucleus. Scale bar: 50 and 10mm,
respectively.
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NF200 marker appears later than BRN3B in RGC devel-
opment [56,93] and is associated with stabilization of neu-
ronal circuitries in developing mammalian CNS. NF200
cytoplasmic staining was found in the basal side of hESC-
derived retinal tissue. We identified numerous NF200 [+]
axons traversing the retinal tissue and migrating along the
apical side. Synaptophysin IHC identified positive cells in
the apical and basal sides of hESC-derived retinal tissue
(Fig. 7b, d). Confocal analysis of single optical sections
identified numerous synaptic boutons around some (but not
FIG. 6. Localization of BRN3B-positive retinal ganglion cells (RGCs) to the basal side of hESC-derived retinal tissue.
Immunostaining of hESC-derived retinal tissue with BRN3B antibody shows the prominent distribution of BRN3B [+] cells
(with acquired RGC fate) in the central part of the section. The large inset represents the magnification of the area marked
with an asterisk and a white arrow. The top small inset depicts a migrating BRN3B [+] cell with an elongated nucleus (*).
The bottom small inset shows a BRN3B [+] cell with a round nucleus (likely mature BRN3B [+] cell) present in the basal
side. Small patches of BRN3B [+] cells were also found in the periphery (**). DAPI-stained nucleus. Scale bar: 50 and
10 mm, respectively.
FIG. 7. Axonogenesis and synaptogenesis in hESC-derived retinal tissue. (a, a¢) Immunostaining of hESC-derived retinal
tissue with antibodies to NF200 (mature axonal marker) and human Synaptophysin (Syn). DAPI-stained nucleus. Scale bar:
20 mm. (b, c, c¢) NF200 [+] axons outgrowing from the basal side, traversing the retinal tissue, and running along the apical
side of hESC-derived retinal section ( purple dots). Scale bar: 50mm. (d) Magnified area shown in b (*) and shows the
presence of Synaptophysin [+] cells in the basal layer. (e, f, f¢) Confocal images demonstrating the presence of many
Synaptophysin [+] synaptic boutons in the apical side. Double asterisk in e marks a group of Synaptophysin [+] cells
depicted in f, magnified image. Scale bar: 20 mm. Arrows point to multiple Synaptophysin [+] boutons. (f) A confocal (z-
stack) image of two cells in e. Scale bar: 20 mm. (f¢) Confocal (z-stack) image of the area marked with white arrows in f. The
stack image was virtually resectioned at the x and y planes to demonstrate the presence of individual synaptic boutons.
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all) cells in the RGC and PR layers (Fig. 7e, f, f¢). We also
observed stretches of synaptic puncta resembling bouton en
passant in the PR and RGC layers (data not shown).
To characterize cells located between the RPE/PR and
RGC/amacrine layers of hESC-derived retinal tissue, we
used anti-DCAMKL1 antibody, a marker of young devel-
oping neurons in the retina (reported at embryonic day 14.5)
and brain [13]. DCAMKL1 is highly expressed during ax-
onogenesis [40,94]. The presence of this marker identifies
commitment to neuronal, but not glial, identity [40]. We
found the cytoplasm of most cells positive for DCAMKL1.
However, the strongest staining was consistently found in
the apical and basal sides (Supplementary Fig. S9).
To confirm the specificity of the IHC signals described
herein, we performed staining of hESC-derived retinal tis-
sue with only secondary antibodies (rabbit Alexa-488 and
mouse Alexa-568 or vice versa) and routinely found no
signal with secondary antibodies alone (Supplementary
Fig. S10).
Electrophysiology of inner retinal neurons
To investigate whether neurons in hESC-derived retinal
tissue are functional, we whole-cell recorded from them and
characterized their intrinsic electrophysiological properties
as well as responses to neurotransmitter receptor agonists.
We targeted cells with medium to large somas (>8mm di-
ameter; Fig. 8a) toward the interior region of the hESC-
derived retinal tissue. Intracellular dye fills of the recorded
cells revealed that they possessed multiple branching pro-
cesses that often extended more than 50mm, confirming that
they were amacrine and/or ganglion cells (Fig. 8a).
We then examined the voltage-step responses of neurons
in hESC-derived retinal tissue at either 6 or 12 weeks of age.
At the younger age (6 weeks), the majority of cells tested (8
of 9) exhibited nearly ohmic current responses (Fig. 8b),
suggesting that most (but not all) cells at this age lacked
functional voltage-gated ion channels. At the more mature
age, however, the responses of all cells studied (n = 12)
displayed pronounced voltage gating. Specifically, all cells
exhibited rapidly inactivating inward currents (Fig. 8c, ar-
rows), which were followed by a slower, more sustained
outward current (Fig. 8c). Similar voltage-gated currents
have been shown to arise from voltage-gated Na+ and K+
channels, respectively [95]. Indeed, when we recorded from
five other cells using an intracellular solution containing
QX-314 (which blocks voltage-gated Na+ channels) and Cs+
(which blocks K+ channels), both voltage-gated response
components were largely eliminated (Fig. 8d). To investi-
gate whether these channels supported the generation of
action potentials, we returned to the normal K+-based in-
tracellular solution and studied voltage responses to a series
of current steps. All five cells tested showed spiking activity
in response to most of the depolarizing current steps (Fig.
8e). Furthermore, in response to the most negative current
steps, all cells exhibited hyperpolarization that sagged over
time (Fig. 8e), reflecting the hyperpolarization-activated
inwardly rectifying current (Ih) [96].
Next, we tested for the presence of functional neurotrans-
mitter receptors in the 12-week-old neurons. All cells tested
(n= 7) responded to5 s puffs of 2mMl-glutamate and of 1mM
muscimol (a GABAA agonist) plus 1mM glycine under both
voltage clamp (Supplementary Fig. S11a, b) and current clamp
(Supplementary Fig. S11c). The voltage-clamp responses to
muscimol+ glycine were increases in conductance and re-
versed near -65mV (Supplementary Fig. S11a, b), reflecting
the opening of inhibitory Cl- channels. The glutamate-induced
responses were also conductance increases, but they remained
inward at the most positive holding potential tested (-33mV)
(Supplementary Fig. S11a, b), consistent with the opening of
excitatory cation channels. When cells were recorded under
zero current clamp, responses to puffed l-glutamate were
depolarizing, whereas responses to muscimol+ glycine were
hyperpolarizing (Supplementary Fig. S11c).
Last, we examined the change in expression of voltage-
gated Na+ and K+ channel genes, SCN1A, SCN2A, KCNA1,
and KCNA6, in 6- and 12-week-old hESC-derived retinal
tissue by qRT-PCR. Our results support the increase in
voltage-gated response in whole-cell recorded cells between
6 weeks (absent to weak) and 12 weeks (robust) (Fig. 8f).
Discussion
The regeneration of normal cellular architecture in the
diseased retina through cell-based therapies will require new
strategies to repair a very delicate and highly organized
retinal tissue. A critical number of PRs need to be func-
tionally reconnected into the retinal circuitry to restore
vision. A number of elegant studies demonstrated the abil-
ity of some grafted PRs to integrate into the PR layer
and synapse onto bipolar neurons [97–99]. However, only a
limited number of PR progenitors, harvested at a narrow
window of time (postnatal days 3–5 for mouse), showed
successful integration [100]. Differentiating PRs in 2D
monolayers further reduce the numbers of PR progenitors
available for successful transplantation as PR development
in 2D cultures is not synchronized. This presents a major
challenge for selecting the right cell population of hESC-
derived PRs for subretinal grafting. In addition, the degen-
erating environment in dystrophic retinas may cause inte-
grated PRs to die [101], similar to degeneration of neurons
transplanted into the brains of Huntington’s patients [102].
The remarkable ability of retinally differentiated hPSCs
to self-organize into rudimentary 3D retinas was first de-
scribed by Sasai laboratory [103]. Compared with PRs dif-
ferentiated in the 2D monolayer [27], PRs derived from
hPSCs develop in a more synchronized manner and are
more likely to be transplantable [104]. Sasai’s discovery
also provided a way to generate immature, but partially
laminated, retina-like human tissue rather than PRs, resem-
bling human embryonic retina, and use it for translational
applications. Recently, several laboratories have demon-
strated the ability of retinospheres to partially recapitulate
retinal development [24–26] using this elegant 3D in vitro
model.
Nevertheless, efforts of grafting 3D retinal tissue derived
from hESCs and iPSCs are still in their infancy. Earlier
attempts in fetal retina transplantation have been reported in
patients [9,29–31], although it is ethically controversial and
quality control and the scalability of the required tissue are
limited. Both limitations can be circumvented by the use
of hPSC-derived retina. However, retinospheres cultured in
suspension are suboptimal for grafting because it is difficult
to cut a flat and large piece of tissue from them and position
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FIG. 8. Inner retinal neurons in 12-week-old hESC-derived retinal tissue aggregates are electrically excitable. (a) Left:
infrared image of a cell being recorded. Right: Lucifer Yellow fill of the same cell. Scale bar is 10 mm. (b–d) Current
responses (top traces) of three different cells to a series of voltage steps (bottom traces). The dark traces highlight responses
to the -13mV step. Each cell’s responses are plotted at a longer timescale (left traces) to show the complete responses and
at a shorter timescale (right traces) to illustrate early components of the responses. (b) Voltage-step responses of a typical 6-
week-old neuron. These responses showed no signs of voltage-gated channels. (c) Voltage-step responses of a 12-week-old
neuron. The transient inward currents (arrows) induced shortly after the capacitive currents were voltage-gated Na+
currents, whereas the slowly decaying outward currents were voltage-gated K+ currents. (d) Voltage-step responses of
another 12-week-old neuron recorded using the Cs+-based intracellular solution containing QX-314. Both voltage-gated Na+
and K+ currents were virtually eliminated. (e) Current step responses of another 12-week-old neuron. The most negative
current step induced a sagging response reflecting Ih, whereas most of the depolarizing steps induced one or more spikes.
The response highlighted in black exhibited repetitive spiking. (f) Quantitative RT-PCR analysis of hESC-derived retina
differentiated for 6 and 12 weeks. Expression values of genes for Na+ and K+ voltage-gated channels, SCN1A, SCN2A,
KCNA1, and KCNA6, are presented as fold change over control (pluripotent hESCs, day 0) using the comparative ddCt
method [41]. Fold ratio of 1 denotes no change in gene expression. GAPDH was used as internal control. The analysis was
done in technical triplicates. RT-PCR, reverse transcription-coupled polymerase chain reation.
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it in the subretinal space (Fig. 9). The extracted tissue would
likely have to be crumbled during isolation [34], which will
reduce tissue’s full developmental potential shown by Seiler
and Aramant [105]. We demonstrate that larger pieces of
hESC-derived retinal tissue, resembling human retinas
during weeks 6–12 of development (Supplementary Table
S4), could be derived in adherent conditions. Culturing
hESC-derived retinal tissue as attached aggregates allows
derivation of long and flat (rather than spherical) pieces of
retina. The retinal markers we tested suggest that our hESC-
derived retinal tissue roughly corresponds to the first tri-
mester of human retinal development; this developmental
stage allows successful survival and differentiation of
human fetal retinal grafts [33]. Specifically, we observed the
organization of hESC-derived retinal tissue into RPE, PR,
and INL/RGC layers. Next, we found many early-born
retinal cells (RPE, RGCs, amacrines) and strong upregula-
tion of Opn1sw (S-Cones, 48.4 – 4.3), while RHO, PKCa,
CALB1, and GLUL (late markers) were undetected by IHC,
and RHO, NRL, NR2E3, PRKCA, GLUL, and CCND3 ex-
pression was low. We also found a number of migrating
cells (typical for embryonic retinogenesis), including ama-
crines, RGCs, and PR progenitors. Our research [27] and
that of other laboratories [32,105] indicates that the sub-
retinal niche may provide further developmental cues for
immature retinal cells. To advance work on designing ret-
inal replacement strategies, we improved our previously
published retinal differentiation protocol [27] to produce
hESC-derived retinal tissue in adherent conditions. Unlike
culturing in suspension, culturing in adherent monolayers
allows the formation of flexible and long stretches of 3D
retinal tissue suitable for subretinal transplantation while
not compromising the temporospatial dynamics of retinal
maturation. The mitotic index in hESC-derived retinal tissue
remained low at 6 weeks (Supplementary Fig. S5), suggesting
that uncontrollable cell growth is highly unlikely. Our hESC-
derived retinal tissue shows striking resemblance to normal
embryonic mammalian retina, including emerging synapto-
genesis (including boutons en passant), robust axonal growth
in the RGC layer, differentiation initiating from the center of
the tissue, distribution of postmitotic PRs along the apical
side, and the migration of amacrines, RGCs, and putative
CRX [+] PR progenitors from the apical to the basal side of
the tissue (Figs. 3–7). The distribution of OTX2 [+] cell
nuclei, which are typically found in PR precursors [54,85],
resembled that in 6–10-week-old human fetal retina [81].
RPE pigmentation together with strong upregulation of
several key RPE signature genes [106] (MITF [RPE iso-
form] [107], DCT, RPE-65, TYR, TYRP, and even PMEL)
suggests the formation of an RPE layer around the hESC-
derived retinal tissue, providing additional evidence for
self-organization and polarization of this tissue. We noted
that PMEL (human homolog of the Silver gene in mice),
which is responsible for melanocyte granule formation,
was upregulated about sevenfold by 6 weeks in hESC-
derived retinal tissue. Interestingly, in cases when we
found RPE-like cells on the basal side of hESC-derived
retinal tissue, we observed some immature recoverin [+]
PRs on the basal side as well, in line with our findings
that PRs and RPE cells develop in sync during retinogen-
esis and PRs need close proximity to the RPE to mature
and develop OSs [2]. However, we cannot exclude the
possibility that these RCVRN [+] cells were cone bipolar
neurons [108,109].
We found PNA lectin signal in the apical side of hESC-
derived retinal tissue, which looked like either puncta or
small stubby protrusions (Fig. 5d, inset). PNA is very spe-
cific to cone, but not rod, PRs [110]. In chick retina, it was
detected as early as embryonic day 7, although Mu¨ller glia
was also noted to be PNA immunopositive [111]. Because
we did not detect any Mu¨ller glia-specific markers (GLUL,
CCND3) by IHC and by qRT-PCR, we conclude that the
PNA [+] staining belongs to cones. Our hESC-derived ret-
inal tissue probably only approximates the timing of the
developmental processes in mammalian retinogenesis.
Therefore, the expression onset of some markers in hESC-
derived retinal tissue may not exactly match what happens
in developing mammalian retina. However, the PNA signal
in the apical side was an encouraging observation as robust
PR development in hESC-derived retinal tissue is a pre-
requisite for vision restoration after retinal grafting.
Our current culturing conditions are unlikely to support
the development of PR OSs, which requires a mature RPE
with apical microvilli [2]. Nevertheless, our observation that
PRs do develop in our hESC-derived retinal tissue suggests
that hESC-derived retina might form PR OSs after being
grafted subretinally, together with an intact RPE. Our results
also provide reasonable expectation that hESC-derived ret-
inal tissue will slowly complete retinal development in
subretinal grafts, as has been described for grafted human
FIG. 9. Retinal repair strat-
egy using hESC-derived reti-
nal tissue. (a) Strategy to
isolate a long piece of hESC-
derived retinal tissue from the
large aggregate for subretinal
grafting. (b) Presents our esti-
mates of therapeutically im-
portant cell type numbers in
1mm slices of hESC-derived
retinal tissue.
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embryonic retina [105]. The finding of a ciliary margin-like
zone in larger hESC-derived retinal tissue (OTX2 [+], CRX
[+], and LGR5 [+] cells, Figs. 3, 5, and Supplementary Fig.
S6) confirms Sasai’s observation [82]. The identification of
many LGR5 [+] and TERT [+] cells in addition to Ki67 [+]
cells in the apical side of the developing hESC-derived
retinal tissue was intriguing. These data support our finding
that retinal progenitors are born near the apical side of
hESC-derived retinal tissue, similar to that found in mam-
malian retinogenesis [62,63]. In the most thoroughly char-
acterized intestinal crypt stem cell niche, mTERT labels
slow cycling cells [112], while LGR5 [+] marks rapidly
cycling cells. However, both cell types appear to be Ki67
negative. In our hESC-derived retinal tissue, we identified a
small number of strongly Ki67 [+] (mitotic) cells at the
apical side, while more cells were weakly positive, indi-
cating recent mitosis [60]. We used LGR5 as a marker of
glycinergic amacrine cells [69], and we were intrigued by
the fact that LGR5 expression became highly upregulated
after the initiation of hESC-retinal differentiation and re-
mained very strong afterward (Supplementary Table S3),
likely indicating its role in retinogenesis. Collectively, it is
evident that similar to the apical region of the developing
mammalian retina [62,63], the apical side of the hESC-
derived retinal tissue contains cells with progenitor char-
acteristics, which divide there, acquire cell fate, and then
migrate out (Figs. 3–6).
Developmental gradient in hESC-derived
retinal tissue
We discovered patches of BRN3B [+] cells and recoverin
[+] cells located in the periphery of the developing hESC-
derived retinal tissue (Fig. 6 and Supplementary Fig. S8),
while the central region, which was the most developmen-
tally advanced part of the tissue, consistently had high
concentration of these cells. RGC development starts at
the central region of the developing retina and gradually
spreads to the periphery [113]. This maturation pattern also
applies to other cell types during mammalian retinogenesis
[114,115]. Our 6-week-old hESC-derived retinal tissue fol-
lowed that pattern.
RGC axons and maturation
Tracing of NF200 [+] axons allowed the identification of
cells within the BRN3B [+] layer (purple dots, Fig. 7b, c, c¢).
In the absence of the optic nerve, these axons traversed the
tissue and traveled along the apical side. NF200 appears
only in postnatal RGCs in the developing mammalian retina
[116,117], although other markers in our hESC-derived
retinal tissue approximately matched the developmental
stage to 6–10-week-old human fetal retina or embryonic
days 14–15 stage in mouse retinogenesis [46,58,118]. These
data support our conclusion that not all markers follow
precisely their expression time course during retinogenesis.
Cell fate acquisition and maturation are regulated by dif-
ferent intrinsic and extrinsic factors during retinogenesis,
and the lack of many extrinsic developmental signals likely
prevents precise coordination of retinogenesis events in
hESC-derived retinal tissue. We compared our data with
other reports where human fetal retina or hPSC-derived
retinal organoids were studied by IHC (Supplementary
Table S4). This comparison validates our finding of early PR
marker CRX, RCVRN, OTX2, retinal progenitor/PR/RGC
marker PAX6, early RGC marker BRN3B, and amacrine
marker Calretinin in 6-week-old hESC-derived retinal tissue
and also the absence of RHO and R/G opsins.
Synaptogenesis
Establishing synaptic connectivity between the INL of the
graft and the host retina’s RGCs is crucial for vision res-
toration. The robust synaptogenesis by hESC-derived retinal
neurons after transplantation into adult rodent CNS and the
high frequency of human/rat (chimeric) synapse formation
have been demonstrated [40]. Such synapses looked mature
and functional as they had Synaptophysin [+] synaptic
vesicles and postsynaptic densities. Using the same mono-
clonal antibody to human Synaptophysin used in this study,
we show that hESC-derived retinal tissue can initiate sy-
naptogenesis and form multiple boutons on some cells (Fig.
7e–f¢) identical to that found in earlier reports [40,119]. We
project from this finding that our hESC-derived retinal tissue
would be able to synapse with the RGCs of the recipient
retina in subretinal grafts (as shown in Fig. 9) similar to that
reported by Seiler et al. [28]. Transplantation of hPSC-
derived retinal tissue is a promising approach to repair vi-
sion and should be extensively tested in animals with PR
degeneration because in vitro studies can reveal only a
limited amount of translational information.
The size of the hESC-derived retinal tissue
and numbers of therapeutically valuable cell types
Large and elongated hESC-derived retinal tissue aggre-
gates cultured in our conditions were about 150–300 somas
in diameter and 8–12 somas in thickness. We estimated that
an average midsagittal section carried about 80 PRs, 50
amacrines, and 80 RGCs (Fig. 9). Because our sections were
12 mm thick and assuming that every other section within a
1mm slice of hESC-derived retinal tissue produces similar
cell counts, we estimate that a large 1-mm-thick section of
hESC-derived retinal tissue provides about 3,200 PRs, about
2,000 amacrines, and 3,200 RGCs. The size of this 3D
retinal slice is comparable with that used for routine fetal
retinal grafting (2mm2) [105]. The transplant size for human
patients (reported by Seiler and colleagues [9], also personal
communication) was 2–5mm2. The size of the grafts for rat
transplants was about 1–1.5 · 0.6mm [120,121]. Two or
three large pieces of hESC-derived retinal tissue, generated
by our approach, could be grafted together to have a graft of
about 5mm length in size.
Electrophysiology
A recent study showed that retinal tissue derived from
human iPSCs contained all five classes of neurons (rod/cone
PRs, horizontal, bipolar, amacrine, and ganglion) as well as
Mu¨ller glia and that these cells organized systematically into
layers [26]. Furthermore, some PRs responded to light, indi-
cating that they had acquired functional properties in addition
to expressing molecular markers of PRs [26]. In the current
study, we tested whether inner retinal neurons in hESC-
derived retinal tissue have acquired functional characteristics
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in addition to expressing amacrine and RGC markers. We
found that in 6-week-old hESC-derived retinal tissue ag-
gregates, only one of nine recorded cells had significant
voltage-gated currents. By contrast, all 12 tested cells from
12-week-old hESC-derived retinal tissue aggregates ex-
hibited both slowly decaying, Cs+-sensitive outward cur-
rents and rapidly inactivating, QX-314-sensitive inward
currents, indicating the presence of voltage-gated K+ and
Na+ channels, respectively (Fig. 8). These more mature
neurons also generated spikes in response to depolarizing
current injection, suggesting a capacity for long-range signal
propagation. However, these responses usually consisted of
only one spike (see the responses to the four most positive
current steps in Fig. 8e), suggesting that at 12 weeks of age,
these neurons are still not fully developed [122]. Finally, all
12-week-old inner retinal neurons responded to l-glutamate,
muscimol, and/or glycine with reversal potentials expected
for ionotropic glutamate and GABA/glycine receptors
(Supplementary Fig. S11), indicating the presence of both
excitatory and inhibitory receptors. In conclusion, these
more mature neurons should be able to respond to input
from presynaptic bipolar and amacrine cells and to signal to
postsynaptic neurons through spiking. Thus, this retinal
tissue has the potential to perform at least some electro-
physiological functions needed for visual processing. It is
likely that its full potential could be revealed only in sub-
retinal grafts 6–9 months after grafting [32,105].
Limitations of our method include the inability to keep
hESC-derived retinal tissue aggregates for a prolonged pe-
riod of time on the same Matrigel-coated plates and variable
yield (from 2–3 to 15 or more of such aggregates per 35-mm
Petri dish). While we solved the second problem by scaling
up the cultures, maintaining hESC-derived retinal tissue
aggregates on the same Matrigel plates for up to 12 weeks
was challenging. Many of them were gradually dislodging
from degenerating Matrigel. Introducing novel matrices for
longer-term culture of hESC-derived retinal tissue in ad-
herent conditions may provide a significant advancement in
process development leading to the industrial-scale manu-
facture of clinical-grade product. On the other hand, the
developmental stage of our hESC-derived retinal tissue at 6
weeks of differentiation (approximately equal to 6–10-
week-old human fetal retina, Supplementary Table S4) may
be sufficient for successful survival of such grafts in the
subretinal space, and culture for longer periods of time may
generate more mature retinal tissue, which may not survive
retinal grafting [33].
Process and assay development leading to products that
can ultimately be utilized in animal preclinical and subse-
quently human clinical development will likely need to be
performed using clinical good manufacturing practice
(cGMP)-grade hESCs and potentially cells genetically
modified to escape the immune surveillance of the host.
Alternatively, patient-specific iPSCs could be utilized, al-
though patient-specific protocols would be expected to add
significantly to the cost of care. A key aspect of process
development will need to include quality assurance systems
that precisely characterized the cellular component of the
resulting retinal tissues. The characterization of the cellular
components, while not necessarily pluripotent stem cells,
could nevertheless cause inappropriate ectopic tissue for-
mation and will therefore need additional study.
In summary, the key observations of our study are the (1)
ability to partially reproduce early retinogenesis and histo-
genesis in hESC-derived retinal tissue, (2) potential to
generate longer and flexible pieces of retina suitable for
subretinal grafting in adherent conditions, (3) low mitotic
index by 6 weeks after initiation of hESC-> retinal differ-
entiation, indicating low danger of tumorigenesis, (4) ap-
proximate matching of developmental events in hESC-
derived retinal tissue to *6–10 week human fetal retina
(which is close to developmental time point successfully
used for subretinal grafting [105]), and (5) the evidence of
emerging synaptogenesis and electrophysiological activity,
indicating the potential of such hESC-derived retinal tissue
to establish synaptic connectivity in subretinal grafts.
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